Cambrex Corporation Pursues Strategic Alternatives for Rutherford Chemicals

18-Dec-2002

Cambrex Corporation announced today that it has engaged Banc of America Securities LLC as financial advisor to assist the Company in investigating strategic alternatives for its Rutherford chemicals business segment. This engagement supports Cambrex' strategic objective of transitioning from a specialty and fine chemicals company to a leading Life Sciences company serving the human health industry.

"We are looking forward to working with the Banc of America team to help us explore and assess the various alternatives for the Rutherford Chemicals business," commented Sal Guccione, Executive Vice President Corporate Strategy and Development.

Other news from the department business & finance

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance